Global Peritoneal Dialysis Devices Market Size By Type (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)), By Application (Home-Based Dialysis, Dialysis Center And...

The Global Peritoneal Dialysis Devices Market was valued at USD 5.1 billion in 2023 and is projected to reach USD 9.4 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2023–2031). The increasing prevalence of chronic kidney disease (CKD), rising geriatric population, and growing preference for home-based dialysis therapies are the key factors propelling market growth. Peritoneal dialysis (PD) devices offer greater flexibility and improved quality of life for patients compared to hemodialysis, particularly in remote and under-resourced regions.

Drivers:

1. Rising Incidence of End-Stage Renal Disease (ESRD):

The escalating global burden of ESRD is significantly boosting the demand for effective and accessible renal replacement therapies such as peritoneal dialysis. PD devices provide a less invasive and more patient-friendly alternative, fueling market expansion.

2. Shift Toward Home-Based Dialysis Solutions:

Patients and healthcare systems are increasingly adopting home dialysis due to its convenience, cost-effectiveness, and favorable clinical outcomes. This trend is driving the adoption of automated peritoneal dialysis (APD) systems.

3. Technological Advancements in PD Devices:

Innovations such as wearable PD machines, remote monitoring systems, and biocompatible dialysis solutions are enhancing treatment efficacy and safety, thus encouraging wider adoption.

Restraints:

1. Risk of Peritonitis and Complications:

Peritonitis remains a major complication associated with PD, often discouraging both patients and physicians from choosing this modality over hemodialysis.

2. Limited Awareness and Training in Low-Income Regions:

Despite the clinical benefits, limited awareness, lack of skilled caregivers, and inadequate training programs hinder market penetration, especially in developing economies.

Opportunity:

1. Market Expansion in Emerging Economies:

Countries in Asia-Pacific and Latin America present significant growth opportunities due to their expanding healthcare infrastructure and government support for home-based therapies.

2. Integration of IoT and Remote Patient Monitoring:

IoT-enabled PD systems are emerging as a transformative trend, enabling real-time health tracking and early complication detection, particularly benefiting elderly patients.

Market by System Type Insights:

The Automated Peritoneal Dialysis (APD) segment held the largest market share in 2023 and is anticipated to maintain its lead throughout the forecast period. APD systems offer greater convenience by performing dialysis during the night, improving adherence and patient satisfaction. The Continuous Ambulatory Peritoneal Dialysis (CAPD) segment, although still widely used, is expected to grow steadily, especially in rural and low-income settings due to lower operational costs.

Market by End-use Insights:

Homecare settings dominated the market in 2023, capturing over 60% of the revenue share. The preference for home-based treatments has been driven by hospital cost savings, patient autonomy, and increased availability of compact, easy-to-use devices. Hospitals and dialysis centers, however, remain crucial for training, emergency care, and complex cases.

Market by Regional Insights:

North America accounted for the largest market share in 2023, supported by favorable reimbursement policies, high CKD prevalence, and robust healthcare infrastructure. Asia-Pacific is poised to witness the highest CAGR during the forecast period, driven by rising healthcare investments, growing elderly population, and awareness campaigns by public and private entities.

Competitive Scenario:

Key players in the Global Peritoneal Dialysis Devices Market include:

Baxter International Inc.

Fresenius Medical Care AG & Co. KGaA

Nikkiso Co., Ltd.

Medionics International

Terumo Corporation

B. Braun Melsungen AG

Asahi Kasei Corporation

Dialife SA

Cook Medical Inc.

Kawasumi Laboratories Inc.

These companies are focused on expanding their product portfolios, advancing PD technology, and forging partnerships to penetrate emerging markets.

Scope of Work – Global Peritoneal Dialysis Devices Market

Report Metric Details

Market Size (2023) USD 5.1 billion

Projected Market Size (2031) USD 9.4 billion

CAGR (2023–2031) 7.8%

Market Segments By System Type (CAPD, APD), By End